Balchem Corp.
provides specialty ingredients and products for the food, nutritional, feed,
pharmaceutical and medical sterilization industries including (1) specialty
gases used to sterilize medical devices and to produce specialty herbicides,
fertilizers and pharmaceuticals, (2) solutions for microencapsulation,
granulation and agglomeration for applications in food, pharmaceutical and
nutritional ingredients and (3) nutritional products for animals. BCPC has grown profits and dividends at a
20%+ rate over the last five years earning a 15-20% return on equity
The company has been able
to weather the recent economic down turn and should continue to grow as the
rising standard of living throughout the third and emerging worlds lead to
improved diet and healthcare.
BCPC is rated B++ by
Value Line, has no debt and its stock yields .5%.
Statistical Summary
Stock Dividend Payout # Increases
Yield Growth Rate Ratio
Since 2004
BCPC .5% 20% 29 6
Ind Ave 1.7 9 24 NA
Debt/ EPS Down Net Value Line
Equity ROE Since 2004 Margin Rating
BCPC 0% 14% 0 13% B++
Ind Ave 32 17 NA 9 NA
Chart
Note:
BCPC stock made great progress off its March 2009 low, quickly surpassing the
downtrend off its September 2008 high (straight red line) and the November 2008
trading high (green line). Long term it
is in an uptrend (blue lines).
Intermediate term it is in a trading range (purple lines). The wiggly red line is the 50 day moving average.
The Aggressive Growth Portfolio owns a full position in BCPC. The upper boundary of its Buy Value Range is
$53; the lower boundary of its Sell Half Range is $82.
9/14
No comments:
Post a Comment